{"result": "(\"entity\"<|>DERR RL<|>PERSON<|>Derr RL is an author who contributed to research on hyperglycemia and its association with infections during bone marrow transplantation.)\n##\n(\"entity\"<|>HSIAO VC<|>PERSON<|>Hsiao VC is an author involved in the study of hyperglycemia and its risks in critically ill patients.)\n##\n(\"entity\"<|>SAUDEK CD<|>PERSON<|>Saudek CD is an author who researched the impact of hyperglycemia on neutropenic infections in bone marrow transplantation.)\n##\n(\"entity\"<|>OUDMANS-VAN STRAATEN HM<|>PERSON<|>Oudemans-van Straaten HM is an author who studied plasma glutamine depletion and its effects on patient outcomes in acute ICU admissions.)\n##\n(\"entity\"<|>BOSMAN RJ<|>PERSON<|>Bosman RJ is an author who contributed to research on plasma glutamine and patient outcomes in intensive care settings.)\n##\n(\"entity\"<|>TRESKES M<|>PERSON<|>Treskes M is an author involved in the study of glutamine depletion in critically ill patients.)\n##\n(\"entity\"<|>DECHELOTTE P<|>PERSON<|>Déchelotte P is an author who researched the effects of glutamine supplementation in critically ill patients.)\n##\n(\"entity\"<|>HASSELMANN M<|>PERSON<|>Hasselmann M is an author who contributed to the study of glutamine in total parenteral nutrition.)\n##\n(\"entity\"<|>CYNOBER L<|>PERSON<|>Cynober L is an author who studied the role of glutamine in nutrition and its effects on critically ill patients.)\n##\n(\"entity\"<|>ALPERS D<|>PERSON<|>Alpers D is an author who discussed the evidence for glutamine supplementation in humans.)\n##\n(\"entity\"<|>HILL GR<|>PERSON<|>Hill GR is an author who researched the role of gastrointestinal damage in acute graft-versus-host disease.)\n##\n(\"entity\"<|>CROUTHER M<|>PERSON<|>Crowther M is an author who conducted a systematic review on glutamine supplementation in hematopoietic stem cell transplantation.)\n##\n(\"entity\"<|>ANDERSON P<|>PERSON<|>Anderson P is an author who studied the effects of oral glutamine on painful stomatitis during bone marrow transplantation.)\n##\n(\"entity\"<|>AQUINO VM<|>PERSON<|>Aquino VM is an author who researched the use of oral glutamine in preventing mucositis in children undergoing hematopoietic stem cell transplantation.)\n##\n(\"entity\"<|>WARD E<|>PERSON<|>Ward E is an author who conducted a dose-finding study on oral glutamine in pediatric oncology patients.)\n##\n(\"entity\"<|>MITTAL S<|>PERSON<|>Mittal S is an author mentioned in the context of nutritional support in hematological patients.)\n##\n(\"relationship\"<|>DERR RL<|>HSIAO VC<|>Both authors collaborated on research regarding hyperglycemia and its risks during bone marrow transplantation.<|>6)\n##\n(\"relationship\"<|>DERR RL<|>SAUDEK CD<|>Derr RL and Saudek CD co-authored a study on hyperglycemia and its association with infections in critically ill patients.<|>6)\n##\n(\"relationship\"<|>OUDMANS-VAN STRAATEN HM<|>BOSMAN RJ<|>Both authors contributed to research on plasma glutamine and its effects on patient outcomes in intensive care settings.<|>7)\n##\n(\"relationship\"<|>DECHELOTTE P<|>HASSELMANN M<|>Both authors collaborated on research regarding glutamine supplementation in critically ill patients.<|>6)\n##\n(\"relationship\"<|>HILL GR<|>CROUTHER M<|>Both authors have published research related to hematopoietic stem cell transplantation and its complications.<|>7)\n##\n(\"relationship\"<|>ANDERSON P<|>AQUINO VM<|>Both authors studied the effects of glutamine in the context of bone marrow transplantation and mucositis prevention.<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: den E, Bobbaers H, Bouillon R. Intensive Insulin Therapy in the Medical ICU. N Engl J Med 2006; 354 (5): 449-461.\n\n54. Wiener RS, Wiener DC, Larson RJ . Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300:933-944.\n\n55. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care 2008; 31:1972-7.\n\n56. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel H J, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001; 27:84-90.\n\n57. Déchelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coëffier M, Hecketsneiler B et al. L-alanyl-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind multicenter study. Crit Care Med.2006; 34:598-604.\n\n58. Souba WW. Intestinal glutamine metabolism and nutrition. J Nutr Biochem 1993; 4:2-9.\n\n59. Ziegler TR, Daignault NM. Glutamine regulation of human immune cell function. Nutrition 2000; 16:458-459.\n\n60. Alpers D. Glutamine: Do the data support the cause for glutamine supplementation in humans? Gastroenterology 2006; 130:S106-S116.\n\n61. Herrera-Martínez AD, Alhambra Expósito MR, Manzano García G, Molina Puerta MJ, Alfonso Calañas Continente A y cols. Uso de la glutamina en la nutrición parenteral total de pacientes someti-\n\ndos a trasplante de médula ósea. Nutr Hosp. 2015; 31(4):1620-1624\n\n62. Crowther M, Avenell A, Culligan DJ. Systematic review and meta-analysis of studies of glutamine supplementation in haematopoietic stem cell transplantation. Bone Marrow Transplantation (2009) 44, 413–425.\n\n63. Anderson P, Ramsay NKC, Shu XO, Rydholm N, Rogosheske J, Nicklow R et al. Effect of low dose oral glutamine on painful stomatitis during bone marrow transplantation. Blood 1997; 90: 10: S110 (abstr. 977).\n\n64. Anderson PM, Ramsay NK, Shu XO, Rydholm N, Rogoshesk J, Nicklow R et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 1998; 22: 339–344.\n\n65. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH et al. A double-blind randomized placebo controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant 2005; 36: 611–616.\n\n66. Ward E, Picton S, Reid U, Thomas D, Gardener C, Smith M et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr 2003; 57: 31–36.\n\n67. Welbourne T. Increased plasma bicarbonate and growth hormone after an oral glutamine load. Am J Clin Nutr 1995; 61: 1058–1061.\n\n68. Antin J, Ferrara J. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964–2968.\n\n69. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L,Ferrara JLM. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204–3213.\n\n70. Zhou H, Hu J, Zhang D, Huang W, Yi X, Li D et al. Effects of glutamine supplementation on Th1/Th2 cytokines level in patients undergoing hematopoietic stem cell transplantation. Chin J Clin Nutr 2006; 14: 365–368.\n\n71. Avenell A. Glutamine in critical care: current evidence from systematic reviews. Proc Nutr Soc 2006; 65: 236–241.\n\n72. Bozzetti F. Nutrition support in patients with cancer. In: Payne-James J, Grimble G, Silk D (eds). Artificial Nutrition Support in Clinical Practice, 1st edn. Greenwich Medical Media: London, 2001, pp 639–680.\n\n73. Zhou H, Hu J, Zhang D, Huang W, Yi X, Li D et al. Effects of glutamine supplementation on Th1/Th2 cytokines level in patients undergoing hematopoietic stem cell transplantation. Chin J Clin Nutr 2006; 14: 365–368.\n---\nTema 41. Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad)...    673\n\n74. Mittal S,\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>N ENGL J MED<|>ORGANIZATION<|>The New England Journal of Medicine is a prestigious medical journal that publishes research articles and reviews in the field of medicine.)\n##\n(\"entity\"<|>JAMA<|>ORGANIZATION<|>The Journal of the American Medical Association is a peer-reviewed medical journal that publishes original research, reviews, and opinion pieces in the field of medicine.)\n##\n(\"entity\"<|>DIABETES CARE<|>ORGANIZATION<|>Diabetes Care is a journal that publishes research on diabetes and its complications, including clinical and epidemiological studies.)\n##\n(\"entity\"<|>INTENSIVE CARE MED<|>ORGANIZATION<|>Intensive Care Medicine is a journal that focuses on research and clinical practice in the field of intensive care medicine.)\n##\n(\"entity\"<|>CRIT CARE MED<|>ORGANIZATION<|>Critical Care Medicine is a journal that publishes research related to critical care and intensive care medicine.)\n##\n(\"entity\"<|>BONE MARROW TRANSPLANTATION<|>ORGANIZATION<|>Bone Marrow Transplantation is a journal that publishes research on hematopoietic stem cell transplantation and related fields.)\n##\n(\"entity\"<|>NUTR HOSP<|>ORGANIZATION<|>Nutritional Hospital is a journal that focuses on clinical nutrition and its application in hospital settings.)\n##\n(\"entity\"<|>CHIN J CLIN NUTR<|>ORGANIZATION<|>Chinese Journal of Clinical Nutrition publishes research related to clinical nutrition and dietary practices in China.)\n##\n(\"entity\"<|>GLUTAMINE<|>EVENT<|>Glutamine is an amino acid that plays a role in various metabolic processes and is often studied for its effects on health, particularly in critical care and transplantation settings.)\n##\n(\"entity\"<|>HEMATOPOIETIC STEM CELL TRANSPLANTATION<|>EVENT<|>Hematopoietic stem cell transplantation is a medical procedure used to treat certain cancers and blood disorders by replacing damaged or diseased bone marrow.)\n##\n(\"relationship\"<|>N ENGL J MED<|>JAMA<|>Both journals publish significant research in the field of medicine, often covering overlapping topics related to critical care and patient outcomes.<|>7)\n##\n(\"relationship\"<|>N ENGL J MED<|>DIABETES CARE<|>The New England Journal of Medicine and Diabetes Care both publish research related to critical care and diabetes management.<|>6)\n##\n(\"relationship\"<|>DIABETES CARE<|>JAMA<|>Both journals publish studies that may address similar health issues, particularly in critically ill patients with diabetes.<|>6)\n##\n(\"relationship\"<|>INTENSIVE CARE MED<|>CRIT CARE MED<|>Both journals focus on research and clinical practices in intensive care settings, often publishing complementary studies.<|>8)\n##\n(\"relationship\"<|>BONE MARROW TRANSPLANTATION<|>HEMATOPOIETIC STEM CELL TRANSPLANTATION<|>The journal Bone Marrow Transplantation publishes research specifically related to hematopoietic stem cell transplantation procedures and outcomes.<|>9)\n##\n(\"relationship\"<|>NUTR HOSP<|>GLUTAMINE<|>Nutritional Hospital publishes studies on nutritional support, including the use of glutamine in clinical settings.<|>7)\n##\n(\"relationship\"<|>CHIN J CLIN NUTR<|>GLUTAMINE<|>The Chinese Journal of Clinical Nutrition publishes research on dietary practices, including the effects of glutamine supplementation in clinical nutrition.<|>6)\n<|COMPLETE|>"}]}